Ncardia
Maastricht, Netherlands· Est.
At Ncardia, we are pioneers in iPSC technology providing high-quality cells, relevant screening assays and robust iPSC differentiation processes, with an excellent customer service.
Private Company
Total funding raised: $24M
About
At Ncardia, we are pioneers in iPSC technology providing high-quality cells, relevant screening assays and robust iPSC differentiation processes, with an excellent customer service.
Cell TherapyRegenerative Medicine
Funding History
2Total raised:$24M
Series B$14M
Series A$10M